Vesugen 10 mg
Identified in primary research as the tripeptide Lys-Glu-Asp.
CAD $62.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0178 Listed amount per vial: 10 mg Sales unit: 1 vial
Read the research in context.
Identified in primary research as the tripeptide Lys-Glu-Asp.
- Epigenetic Aspects of Peptidergic Regulation of Vascular Endothelial Cell Proliferation In Aging — source
- [Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis] — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Confirm Lys-Glu-Asp sequence, stereochemistry, termini and counterion; do not confuse with Lys-Glu-Asp-Ala (Livagen). Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for Vesugen, product reference MRD-0178.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 10 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.